Targeted manipulation of m6A RNA modification through CRISPR-Cas-based strategies

被引:15
|
作者
Sun, Xiang [1 ,2 ]
Wang, Dan Ohtan [3 ,4 ,5 ]
Wang, Jinkai [1 ,2 ,6 ]
机构
[1] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Med Informat, Guangzhou 510080, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Ctr Stem Cell Biol & Tissue Engn, Key Lab Stem Cells & Tissue Engn, Minist Educ, Guangzhou 510080, Guangdong, Peoples R China
[3] RIKEN, Ctr Biosyst Dynam Res, Chuo Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan
[4] Kyoto Univ, Grad Sch Biostudies, Yoshida Hon Machi, Kyoto 6068501, Japan
[5] Shenyang Pharmaceut Univ, Wuya Coll Innovat, Shenyang 110016, Liaoning, Peoples R China
[6] Sun Yat Sen Univ, RNA Biomed Inst, Sun Yat Sen Mem Hosp, Guangzhou 510080, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
N-6-methyladenosine; CRISPR-Cas13; CRISPR-Cas9; Targeted manipulation; N-6-METHYLADENOSINE; RECOGNITION;
D O I
10.1016/j.ymeth.2022.03.006
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
N-6-methyladenosine (m(6)A) is a reversible and prevalent internal modification in RNAs and can be dynamically modulated by methyltransferase and demethylase. Targeted manipulation of m(6)A RNA modification is critical in studying the functions of specific m(6)A sites as well as developing molecular therapies through targeting m(6)A. The CRISPR-Cas systems including CRISPR-Cas9 and CRISPR-Cas13 have been widely used to edit and modify specific nucleotides on DNA and RNA through fusing effective proteins such as enzymes with Cas9/13. Through taking advantage of the m(6)A methyltransferase and demethylase, a series of CRISPR-Cas-based methods have also been developed to manipulate the m(6)A methylation at specific RNA sites. This review summarizes the latest CRISPR-Cas13 and Cas9 toolkits for m(6)A site-specific manipulation, including fundamental components, on-target efficiency, editing window, PAM/PFS requirement, and subcellularly localized targeting as well as potential limitations. We thus aim to provide an overview to assist researchers to choose an optimal tool to manipulate m(6)A for different purposes and also point out possible optimization strategies.
引用
收藏
页码:56 / 61
页数:6
相关论文
共 50 条
  • [21] CRISPR-based m6A modification and its potential applications in telomerase regulation
    Yi, Mingliang
    Wang, Mingyue
    Xu, Yongjie
    Cao, Zhikun
    Ling, Yinghui
    Zhang, Zijun
    Cao, Hongguo
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
  • [22] RNA modification A new m6A reader complex
    Trosch, Raphael
    NATURE PLANTS, 2025, 11 (01) : 8 - 8
  • [23] Targeting the RNA m6A modification for cancer immunotherapy
    Li, Xinxin
    Ma, Shoubao
    Deng, Youcai
    Yi, Ping
    Yu, Jianhua
    MOLECULAR CANCER, 2022, 21 (01)
  • [24] RNA m6A modification meets plant hormones
    Shen, Lisha
    Yu, Hao
    NATURE PLANTS, 2025,
  • [25] Targeting the RNA m6A modification for cancer immunotherapy
    Xinxin Li
    Shoubao Ma
    Youcai Deng
    Ping Yi
    Jianhua Yu
    Molecular Cancer, 21
  • [26] RNA m6A modification and its function in diseases
    Tong, Jiyu
    Flavell, Richard A.
    Li, Hua-Bing
    FRONTIERS OF MEDICINE, 2018, 12 (04) : 481 - 489
  • [27] Meclofenamic acid represses spermatogonial proliferation through modulating m6A RNA modification
    Tao Huang
    Jiayin Guo
    Yinghua Lv
    Yi Zheng
    Tongying Feng
    Qiang Gao
    Wenxian Zeng
    Journal of Animal Science and Biotechnology, 10
  • [28] Meclofenamic acid represses spermatogonial proliferation through modulating m6A RNA modification
    Huang, Tao
    Guo, Jiayin
    Lv, Yinghua
    Zheng, Yi
    Feng, Tongying
    Gao, Qiang
    Zeng, Wenxian
    JOURNAL OF ANIMAL SCIENCE AND BIOTECHNOLOGY, 2019, 10 (1)
  • [29] Importance of m N6-methyladenosine (m6A) RNA modification in cancer
    Tuncel, Gulten
    Kalkan, Rasime
    MEDICAL ONCOLOGY, 2019, 36 (04)
  • [30] Emerging role of RNA m6A modification in aging regulation
    Zeming Wu
    Si Wang
    Juan Carlos Izpisua Belmonte
    Weiqi Zhang
    Jing Qu
    Guang-Hui Liu
    Current Medicine, 1 (1):